• Western blot analysis of A549 cells using PEG3 Polyclonal Antibody

Anti-PEG3 antibody (1031-1080 aa) (STJ95024)

SKU:
STJ95024

Current Stock:
Host: Rabbit
Applications: WB/IHC
Reactivity: Human/Rat/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Paternally-expressed gene 3 protein (1031-1080 aa) is suitable for use in Western Blot and Immunohistochemistry research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
IHC-P 1:50-300
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: PEG3
Gene ID: 5178
Uniprot ID: PEG3_HUMAN
Immunogen Region: 1031-1080 aa
Specificity: PEG3 Polyclonal Antibody detects endogenous levels of PEG3 protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human PEG3 at the amino acid range 1031-1080
Function Induces apoptosis in cooperation with SIAH1A. Acts as a mediator between p53/TP53 and BAX in a neuronal death pathway that is activated by DNA damage. Acts synergistically with TRAF2 and inhibits TNF induced apoptosis through activation of NF-kappa-B. Possesses a tumor suppressing activity in glioma cells.
Protein Name Paternally-Expressed Gene 3 Protein
Zinc Finger And Scan Domain-Containing Protein 24
Cellular Localisation Nucleus
Cytoplasm
Alternative Antibody Names Anti-Paternally-Expressed Gene 3 Protein antibody
Anti-Zinc Finger And Scan Domain-Containing Protein 24 antibody
Anti-PEG3 antibody
Anti-KIAA0287 antibody
Anti-ZSCAN24 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance